{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:43:02Z","timestamp":1773675782760,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.lpm.2007.03.037","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T06:00:16Z","timestamp":1201327216000},"page":"e25-e35","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Traitements actuels et perspectives th\u00e9rapeutiques dans la maladie de Beh\u00e7et"],"prefix":"10.1016","volume":"37","author":[{"given":"Mohamed Habib","family":"Houman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Smiti-Khanfir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.03.037_bib1","first-page":"1078","article-title":"criteria for diagnostic of Beh\u00e7et\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.03.037_bib2","first-page":"512","article-title":"History and development of Beh\u00e7et\u2019s disease","volume":"63","author":"Dilsen","year":"1996","journal-title":"Rev Rhum"},{"key":"10.1016\/j.lpm.2007.03.037_bib3","first-page":"488","article-title":"Epidemiology of Adamantiades-Beh\u00e7et\u2019s disease","volume":"150","author":"Zouboulis","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.lpm.2007.03.037_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Beh\u00e7et\u2019s disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.03.037_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.1990.tb05122.x","article-title":"Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Beh\u00e7et\u2019s disease","volume":"79","author":"Hamzaoui","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2007.03.037_bib6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Beh\u00e7et\u2019s disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et\u2019s disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et\u2019s disease: Relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2007.03.037_bib9","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et\u2019s syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0248-8663(97)83701-0","article-title":"Pr\u00e9sentation pseudotumorale de neuro-Beh\u00e7et: r\u00f4le de l\u2019arr\u00eat de la colchicine?","volume":"19","author":"Vignes","year":"1998","journal-title":"Rev Med Int."},{"key":"10.1016\/j.lpm.2007.03.037_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et\u2019s disease a double-blind, placebo-controlled study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et\u2019s syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et\u2019s syndrome: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000246336","article-title":"Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Beh\u00e7et\u2019s disease","volume":"192","author":"Calguneri","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.lpm.2007.03.037_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0714.2004.00265.x","article-title":"Clinical and immunological effects of azithromycin in Beh\u00e7et\u2019s disease","volume":"34","author":"Mumcu","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successfull treatment of Beh\u00e7et\u2019s disease with pentoxxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et\u2019s syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Beh\u00e7et\u2019s disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.lpm.2007.03.037_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporine A versus pulsed cyclophosphamide in Beh\u00e7et\u2019s syndrome: a single masked trial","volume":"76","author":"\u00d6zyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et\u2019s disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.03.037_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporine A therapy in severe uveitis of Beh\u00e7et\u2019s disease","volume":"76","author":"Sullu","year":"1998","journal-title":"Acta Ophtalmol Scand."},{"issue":"suppl","key":"10.1016\/j.lpm.2007.03.037_bib22","first-page":"S356","article-title":"Methotrexate for ocular lesions of Beh\u00e7et\u2019s disease. Cohort study on 262 patients (abstr)","volume":"41","author":"Davatchi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000060761","article-title":"Medical management of Beh\u00e7et\u2019s syndrome","volume":"31","author":"Yazici","year":"1999","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0248-8663(02)00621-5","article-title":"Les manifestations neurologiques de la maladie de Beh\u00e7et","volume":"23","author":"Houman","year":"2002","journal-title":"Rev Med Int."},{"key":"10.1016\/j.lpm.2007.03.037_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Beh\u00e7et\u2019s disease and the nervous system","volume":"245","author":"Serdarglu","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2007.03.037_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11940-000-0042-x","article-title":"Beh\u00e7et\u2019s Disease","volume":"2","author":"Siva","year":"2000","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.lpm.2007.03.037_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","article-title":"Low dose MTX for progressive neuro-Beh\u00e7et\u2019s disease. A follow-up study for 4 years","volume":"528","author":"Kikuchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.lpm.2007.03.037_bib28","first-page":"1","article-title":"CNS involvement occurs more frequently in patients with Beh\u00e7et\u2019s disease under cyclosporin A (CSA) than under other medications-results of a retrospective analysis of 117 cases","author":"Kotter","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Beh\u00e7et disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.lpm.2007.03.037_bib30","first-page":"48","article-title":"Deep vein thrombosis in Beh\u00e7et\u2019s disease","volume":"19","author":"Houman","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0953-6205(02)00134-6","article-title":"Association of right heart thromboses, endomyocardial fibrosis and pulmonary artery aneurysm in Beh\u00e7et\u2019s disease","volume":"13","author":"Houman","year":"2002","journal-title":"Eur J Int Med."},{"key":"10.1016\/j.lpm.2007.03.037_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.bor.0000145520.76348.dd","article-title":"Major vessel involvement in Beh\u00e7et disease","volume":"17","author":"Calamia","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib33","first-page":"402","article-title":"Vascular involvement in BD","volume":"19","author":"Ko\u00e7","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib34","first-page":"614","article-title":"Vascular Involvement in Beh\u00e7et\u2019s Disease","volume":"4","author":"Espinosa","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.lpm.2007.03.037_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current Concepts in the Etiology and Treatment of Beh\u00e7et Disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","article-title":"Vasculitis in Beh\u00e7et\u2019s disease","volume":"16","author":"O\u2019Duffy","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.lpm.2007.03.037_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1540-8175.2001.00015.x","article-title":"A recurrent right atrial thrombus in a patient with Beh\u00e7et\u2019s disease","volume":"18","author":"Dincer","year":"2001","journal-title":"Echocardiography"},{"key":"10.1016\/j.lpm.2007.03.037_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0398-0499(04)96738-8","article-title":"Tromboses intracardiques au cours de la maladie de Beh\u00e7et","volume":"29","author":"Ben Ghorbel","year":"2004","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.lpm.2007.03.037_bib39","first-page":"152","article-title":"Abdominal aortic aneurysm in Beh\u00e7et\u2019s disease: new treatment options for an old and challenging problem","volume":"6","author":"Nitecki","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.lpm.2007.03.037_bib40","first-page":"162","article-title":"Arterial involvement in Beh\u00e7et\u2019s disease-the search for new treatment strategies","volume":"6","author":"Robenshtok","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.lpm.2007.03.037_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1583\/03-1037.1","article-title":"Endovascular repair of concomitant celiac trunk and abdominal aortic aneurysms in a patient with Beh\u00e7et\u2019s disease","volume":"11","author":"Bautista-Hernandez","year":"2004","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.lpm.2007.03.037_bib42","first-page":"2103","article-title":"Arterial lesions in Beh\u00e7et\u2019s disease: a study in 25 patients","volume":"22","author":"Le Thi Huong","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib43","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon alfa","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Beh\u00e7et\u2019s disease with sight threatening posterior or panuveitis","volume":"87","author":"Kotter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","article-title":"Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Beh\u00e7et\u2019s disease","volume":"8","author":"Wechsler","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"issue":"Suppl 4","key":"10.1016\/j.lpm.2007.03.037_bib47","doi-asserted-by":"crossref","first-page":"495s","DOI":"10.1016\/S0248-8663(02)00665-3","article-title":"Interferons and Beh\u00e7et\u2019s disease","volume":"23","author":"Wechsler","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2007.03.037_bib48","first-page":"S647","volume":"52","author":"Seyahi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The Use of Interferon \u03b1 in Beh\u00e7et Disease: Review of the Literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.1999.59","article-title":"Ocular complications with high-dose interferon alpha in chronic active hepatitis","volume":"13","author":"Kadayifcilar","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.lpm.2007.03.037_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002770050255","article-title":"Beh\u00e7et\u2019s disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Beh\u00e7et\u2019s symptoms","volume":"74","author":"Budak-Alpdogan","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lpm.2007.03.037_bib52","first-page":"S6","article-title":"Beh\u00e7et\u2019s disease: an update on the pathogenesis","volume":"19","author":"Gul","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor alpha in clinical uveitis","volume":"33","author":"Santos Lacomba","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.lpm.2007.03.037_bib54","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","article-title":"Epidemiological features and visual prognosis of Beh\u00e7et\u2019s disease","volume":"43","author":"Ando","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib55","first-page":"98","article-title":"Short-Term Trial of Etanercept in Beh\u00e7et\u2019s Disease: A Double Blind, Placebo Controlled Study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib56","first-page":"S181","article-title":"The response of treatment resistant uveitis in Beh\u00e7et\u2019s syndrome [BS] to a TNF-a blocker, etanercept: an open study","volume":"46","author":"Melikoglu","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight threatening panuveitis in Beh\u00e7et\u2019s disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.03.037_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.11204","article-title":"Treatment with infliximab for a child with Beh\u00e7et\u2019s disease","volume":"49","author":"Saulsburg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et\u2019s disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2007.03.037_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.61.3.283-a","article-title":"Remission of Beh\u00e7et\u2019s syndrome with TNF alpha blocking treatment","volume":"61","author":"Rozenbaum","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.03.037_bib61","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joesph","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.lpm.2007.03.037_bib62","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of Infliximab therapy for refractory uveitis","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophtalmol (Paris)"},{"key":"10.1016\/j.lpm.2007.03.037_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-4-19","article-title":"Remission of Beh\u00e7et\u2019s desease with anti-tumor necrosis factor monoclonal antibody therapy: a case report","volume":"4","author":"Gulli","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.lpm.2007.03.037_bib64","first-page":"S181","article-title":"Treatment of refractory vitritis in Beh\u00e7et disease with infliximab","volume":"46","author":"Arayssi","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"suppl 2","key":"10.1016\/j.lpm.2007.03.037_bib65","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Beh\u00e7et\u2019s disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.03.037_bib66","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulceration of Beh\u00e7et\u2019s syndrome with infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"suppl. 34","key":"10.1016\/j.lpm.2007.03.037_bib68","first-page":"S14","article-title":"Infliximab in refractory uveitis due to Beh\u00e7et\u2019s disease","volume":"22","author":"Wechsler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib69","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2019s disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib70","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0755-4982(05)84079-5","article-title":"Infliximab in the treatment of posterior uveitis in Beh\u00e7et\u2019s disease. Long term follow-up in four patients","volume":"34","author":"Lanthier","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib71","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et\u2019s disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.03.037_bib72","unstructured":"Lowder CJ, Galor A, Perez VL. Differential effectiveness of etanercept and infliximab in ocular inflammation. Poster 351 presented at the 2005 Annual Meeting of the Arvo (the Association for Research in Vision and Ophthalmology). Disponible sur: www.arvo.org."},{"key":"10.1016\/j.lpm.2007.03.037_bib73","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.03.037_bib74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210401400515","article-title":"Infliximab for the treatment of posterior uveitis with retinal neovascularization in Beh\u00e7et disease","volume":"14","author":"Giansanti","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.lpm.2007.03.037_bib75","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1345\/aph.1D361","article-title":"Effect of infliximab on refractory uveitis in Beh\u00e7et\u2019s disease","volume":"38","author":"Sayarlioglu","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lpm.2007.03.037_bib76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","article-title":"Beh\u00e7et\u2019s ileocolitis: successful treatment with tumor necrosis factor-alpha antibody [infliximab] therapy: report of a case","volume":"46","author":"Kram","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.lpm.2007.03.037_bib77","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","article-title":"Successful treatment of genital ulcers with infliximab in Beh\u00e7et\u2019s disease","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.03.037_bib78","first-page":"S57","article-title":"Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Beh\u00e7et\u2019s disease","volume":"21","author":"Andonopoulos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib79","first-page":"181","article-title":"Successful Treatment of Long-standing Neuro-Beh\u00e7et\u2019s Disease with Infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib80","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/0-306-48382-3_113","article-title":"Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Beh\u00e7et\u2019s disease","volume":"528","author":"Behrens","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.lpm.2007.03.037_bib81","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-b","article-title":"Beh\u00e7et\u2019s syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib82","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2001.29035","article-title":"Transmembrane TNF-a, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn\u2019s disease","volume":"121","author":"Van Deventer","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2007.03.037_bib83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mog.0000196151.74819.8e","article-title":"Complications of biological therapy for inflammatory bowel diseases","volume":"22","author":"Blonski","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.lpm.2007.03.037_bib84","first-page":"3233","article-title":"Humn S-antigen determinant recognition in uveitis","volume":"42","author":"De Smet","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.lpm.2007.03.037_bib85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Beh\u00e7et\u2019s disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2007.03.037_bib86","first-page":"69","article-title":"Autologous Hematopoietic Stem-Cell Transplantation for Beh\u00e7et\u2019s Disease with Pulmonary Involvement","volume":"344","author":"Breitbart","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.03.037_bib87","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2003-10-3617","article-title":"Autologous hematopoietic stem cell transplantation for severe\/refractory intestinal Beh\u00e7et disease","volume":"103","author":"Rossi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2007.03.037_bib88","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/keg424","article-title":"Remission induction in Beh\u00e7et\u2019s disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H","volume":"42","author":"Lockwood","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2007.03.037_bib89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et\u2019s syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2007.03.037_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0009-9120(02)00400-9","article-title":"Effects of vitamin E supplementation on blood antioxidants levels in patients with Beh\u00e7et\u2019s disease","volume":"35","author":"Kokcam","year":"2002","journal-title":"Clin Biochem"},{"key":"10.1016\/j.lpm.2007.03.037_bib91","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1346-8138.2006.00128.x","article-title":"Oral zinc sulfate in the treatment of Beh\u00e7et\u2019s disease: a double blind cross-over study","volume":"33","author":"Sharquie","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.lpm.2007.03.037_bib92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00296-002-0195-x","article-title":"Trace elements and antioxidant enzymes in Beh\u00e7et\u2019s disease","volume":"22","author":"Saglam","year":"2002","journal-title":"Rheumatol Int"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:56:47Z","timestamp":1630609007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0755498207003326"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.03.037","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}